title: Relationship between galectin-3 expression and TRAIL sensitivity in breast cancer.
abstract: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to death receptors expressed on cancer cells and induces apoptosis. Triple-negative breast cancer cell lines are more sensitive to TRAIL or TRAIL-death receptor agonistic monoclonal antibody-induced apoptosis compared with HER-2/neu-overexpressing or luminal cell lines. The paper under evaluation sought to determine whether the His64/Pro64 polymorphism of galectin-3, which is associated with breast cancer incidence, affects sensitivity to TRAIL. None of five breast cancer cell lines homozygous for Pro64 galectin-3 were sensitive to TRAIL, but two out of two homozygous His64 cell lines and one out of two heterozygous His64 cell lines were sensitive. Transfection of galectin-3 null BT549 breast cancer cells with His64 galectin-3 rendered them sensitive to TRAIL, while Pro64 galectin-3-transfected cells remained resistant to TRAIL. This article highlights that galectin-3 receptor expression and genotype may be useful markers in predicting TRAIL or agonistic antibody sensitivity of breast cancer patients.
authors.affiliation: Department of Radiation Oncology, University of Alabama at Birmingham, 1825 University Boulevard, Shelby, Room 701, Birmingham, AL 35294-2182, USA.
authors.forename: Hope M
authors.initials: HM
authors.lastname: Amm
authors.forename: Donald J
authors.initials: DJ
authors.lastname: Buchsbaum